Role of type II pneumocytes in pathogenesis of radiation pneumonitis: dose response of radiation-induced lung changes in the transient high vascular permeability period

Exp Toxicol Pathol. 2004 Dec;56(3):181-7. doi: 10.1016/j.etp.2004.08.003.

Abstract

We studied the dose response of pulmonary changes at 3 weeks after 1-25 Gy irradiation and we investigated the effects of an anti-inflammatory drug. Wistar rats were given a single dose of 1-25Gy irradiation to the thorax. Group one was treated with saline only, while group two was administered subcutaneously a combination of pentoxifylline (35 mg/kg) and dexamethasone (1 mg/kg) twice per week. Lungs were examined histochemically and number of neutrophile granulocytes, alveolar septal thickness, air/tissue ratio, number of alveoli per field, number of type II pneumocytes per alveolus, and occludin 1 expression were measured. A significant dose-dependent depletion of type II pneumocytes was found after irradiation with a dose of 1 Gy and higher. Alveolar neutrophils increased after 1 Gy with a dose dependency noted after 10-25Gy and alveolar septa thickening followed 5-25 Gy. A lower occludin 1 expression was observed in animals irradiated with the doses of 5 20 Gy, indicating an effect on vascular permeability. Anti-inflammatory therapy partially inhibited the increase of neutrophils at all radiation doses and the depletion of type II pneumocytes after doses of 1, 10, and 15 Gy. Occludin 1 did not decrease in the lungs of rats treated with the anti-inflammatory drugs as it did in most rats treated only with saline. Our results suggest that pneumocytes depletion is a major factor responsible for radiation pneumonitis development and that these changes may be compensated for provided radiation doses are below the threshold.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Capillary Permeability / radiation effects*
  • Dexamethasone / therapeutic use
  • Disease Models, Animal
  • Dose-Response Relationship, Radiation
  • Drug Therapy, Combination
  • Immunoenzyme Techniques
  • In Vitro Techniques
  • Male
  • Membrane Proteins / metabolism
  • Neutrophils / pathology
  • Neutrophils / radiation effects
  • Occludin
  • Pentoxifylline / therapeutic use
  • Pulmonary Alveoli / metabolism
  • Pulmonary Alveoli / pathology*
  • Pulmonary Alveoli / radiation effects
  • Radiation Pneumonitis / drug therapy
  • Radiation Pneumonitis / pathology*
  • Radiation-Protective Agents / therapeutic use
  • Rats
  • Rats, Wistar

Substances

  • Anti-Inflammatory Agents
  • Membrane Proteins
  • Occludin
  • Ocln protein, rat
  • Radiation-Protective Agents
  • Dexamethasone
  • Pentoxifylline